Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1995 Aug;72(2):476–479. doi: 10.1038/bjc.1995.358

Mammographic densities as a criterion for entry to a clinical trial of breast cancer prevention.

N F Boyd 1, E Fishell 1, R Jong 1, J C MacDonald 1, R K Sparrow 1, I S Simor 1, V Kriukov 1, G Lockwood 1, D Tritchler 1
PMCID: PMC2033973  PMID: 7640235

Abstract

The most convincing evidence that a factor such as dietary fat is causally related to breast cancer would be obtained from a randomised controlled trial in which exposure to dietary fat intake was systematically varied. A limitation of randomised controlled trials of breast cancer prevention, however, is the large sample size required to detect plausible reductions in risk resulting from the intervention. We describe here experience over a period of 9 years with the use of one risk factor for breast cancer as a criterion for entry to a clinical trial of breast cancer prevention. The risk factor used was the presence of extensive densities in the breast tissue on mammography, which has been found by several investigators to be strongly associated with risk of breast cancer. Using this criterion for selection, 1800 subjects of mean age 46 years were enrolled between 1982 and 1986, and again between 1988 and the present. Throughout this period, the point estimate of annual invasive cancer incidence was approximately 6 per 1000 per year. The observed cancer incidence has been consistently 4-5 times the incidence expected from age-specific breast cancer incidence data for women living in Ontario. These data show that the selection of subjects for a clinical trial of breast cancer prevention using the criterion of extensive breast parenchymal densities does identify a group at substantially increased risk of breast cancer. Use of this criterion for the selection of subjects can substantially reduce the sample size required for a clinical trial of a preventive strategy.

Full text

PDF
476

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baanders A. N., de Waard F. Breast cancer in Europe: the importance of factors operating at an early age. Eur J Cancer Prev. 1992 Jun;1(4):285–291. [PubMed] [Google Scholar]
  2. Bailar J. C., 3rd, Smith E. M. Progress against cancer? N Engl J Med. 1986 May 8;314(19):1226–1232. doi: 10.1056/NEJM198605083141905. [DOI] [PubMed] [Google Scholar]
  3. Block G. Vitamin C and cancer prevention: the epidemiologic evidence. Am J Clin Nutr. 1991 Jan;53(1 Suppl):270S–282S. doi: 10.1093/ajcn/53.1.270S. [DOI] [PubMed] [Google Scholar]
  4. Boyd N. F., Byng J. W., Jong R. A., Fishell E. K., Little L. E., Miller A. B., Lockwood G. A., Tritchler D. L., Yaffe M. J. Quantitative classification of mammographic densities and breast cancer risk: results from the Canadian National Breast Screening Study. J Natl Cancer Inst. 1995 May 3;87(9):670–675. doi: 10.1093/jnci/87.9.670. [DOI] [PubMed] [Google Scholar]
  5. Boyd N. F., Cousins M., Beaton M., Fishell E., Wright B., Fish E., Kriukov V., Lockwood G., Tritchler D., Hanna W. Clinical trial of low-fat, high-carbohydrate diet in subjects with mammographic dysplasia: report of early outcomes. J Natl Cancer Inst. 1988 Oct 5;80(15):1244–1248. doi: 10.1093/jnci/80.15.1244. [DOI] [PubMed] [Google Scholar]
  6. Boyd N. F., Cousins M., Beaton M., Kriukov V., Lockwood G., Tritchler D. Quantitative changes in dietary fat intake and serum cholesterol in women: results from a randomized, controlled trial. Am J Clin Nutr. 1990 Sep;52(3):470–476. doi: 10.1093/ajcn/52.3.470. [DOI] [PubMed] [Google Scholar]
  7. Boyd N. F., Cousins M., Kriukov V. A randomized controlled trial of dietary fat reduction: the retention of subjects and characteristics of drop outs. J Clin Epidemiol. 1992 Jan;45(1):31–38. doi: 10.1016/0895-4356(92)90185-p. [DOI] [PubMed] [Google Scholar]
  8. Boyd N. F., Cousins M., Lockwood G., Tritchler D. The feasibility of testing experimentally the dietary fat-breast cancer hypothesis. Br J Cancer. 1990 Dec;62(6):878–881. doi: 10.1038/bjc.1990.400. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. Boyd N. F., McGuire V., Shannon P., Cousins M., Kriukov V., Mahoney L., Fish E., Lickley L., Lockwood G., Tritchler D. Effect of a low-fat high-carbohydrate diet on symptoms of cyclical mastopathy. Lancet. 1988 Jul 16;2(8603):128–132. doi: 10.1016/s0140-6736(88)90684-8. [DOI] [PubMed] [Google Scholar]
  10. Boyd N. F., O'Sullivan B., Campbell J. E., Fishell E., Simor I., Cooke G., Germanson T. Bias and the association of mammographic parenchymal patterns with breast cancer. Br J Cancer. 1982 Feb;45(2):179–184. doi: 10.1038/bjc.1982.31. [DOI] [PMC free article] [PubMed] [Google Scholar]
  11. Boyd N. F., O'Sullivan B., Campbell J. E., Fishell E., Simor I., Cooke G., Germanson T. Mammographic signs as risk factors for breast cancer. Br J Cancer. 1982 Feb;45(2):185–193. doi: 10.1038/bjc.1982.32. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Brisson J., Morrison A. S., Kopans D. B., Sadowsky N. L., Kalisher L., Twaddle J. A., Meyer J. E., Henschke C. I., Cole P. Height and weight, mammographic features of breast tissue, and breast cancer risk. Am J Epidemiol. 1984 Mar;119(3):371–381. doi: 10.1093/oxfordjournals.aje.a113755. [DOI] [PubMed] [Google Scholar]
  13. Brisson J., Sadowsky N. L., Twaddle J. A., Morrison A. S., Cole P., Merletti F. The relation of mammographic features of the breast to breast cancer risk factors. Am J Epidemiol. 1982 Mar;115(3):438–443. doi: 10.1093/oxfordjournals.aje.a113321. [DOI] [PubMed] [Google Scholar]
  14. Kelsey J. L. Breast cancer epidemiology: summary and future directions. Epidemiol Rev. 1993;15(1):256–263. doi: 10.1093/oxfordjournals.epirev.a036112. [DOI] [PubMed] [Google Scholar]
  15. London S. J., Colditz G. A., Stampfer M. J., Willett W. C., Rosner B., Speizer F. E. Prospective study of relative weight, height, and risk of breast cancer. JAMA. 1989 Nov 24;262(20):2853–2858. [PubMed] [Google Scholar]
  16. Longnecker M. P., Berlin J. A., Orza M. J., Chalmers T. C. A meta-analysis of alcohol consumption in relation to risk of breast cancer. JAMA. 1988 Aug 5;260(5):652–656. [PubMed] [Google Scholar]
  17. Ma L., Fishell E., Wright B., Hanna W., Allan S., Boyd N. F. Case-control study of factors associated with failure to detect breast cancer by mammography. J Natl Cancer Inst. 1992 May 20;84(10):781–785. doi: 10.1093/jnci/84.10.781. [DOI] [PubMed] [Google Scholar]
  18. Oza A. M., Boyd N. F. Mammographic parenchymal patterns: a marker of breast cancer risk. Epidemiol Rev. 1993;15(1):196–208. doi: 10.1093/oxfordjournals.epirev.a036105. [DOI] [PubMed] [Google Scholar]
  19. Prentice R. L., Kakar F., Hursting S., Sheppard L., Klein R., Kushi L. H. Aspects of the rationale for the Women's Health Trial. J Natl Cancer Inst. 1988 Aug 3;80(11):802–814. doi: 10.1093/jnci/80.11.802. [DOI] [PubMed] [Google Scholar]
  20. Saftlas A. F., Hoover R. N., Brinton L. A., Szklo M., Olson D. R., Salane M., Wolfe J. N. Mammographic densities and risk of breast cancer. Cancer. 1991 Jun 1;67(11):2833–2838. doi: 10.1002/1097-0142(19910601)67:11<2833::aid-cncr2820671121>3.0.co;2-u. [DOI] [PubMed] [Google Scholar]
  21. Saftlas A. F., Szklo M. Mammographic parenchymal patterns and breast cancer risk. Epidemiol Rev. 1987;9:146–174. doi: 10.1093/oxfordjournals.epirev.a036300. [DOI] [PubMed] [Google Scholar]
  22. Saftlas A. F., Wolfe J. N., Hoover R. N., Brinton L. A., Schairer C., Salane M., Szklo M. Mammographic parenchymal patterns as indicators of breast cancer risk. Am J Epidemiol. 1989 Mar;129(3):518–526. doi: 10.1093/oxfordjournals.aje.a115163. [DOI] [PubMed] [Google Scholar]
  23. Self S., Prentice R., Iverson D., Henderson M., Thompson D., Byar D., Insull W., Gorbach S. L., Clifford C., Goldman S. Statistical design of the Women's Health Trial. Control Clin Trials. 1988 Jun;9(2):119–136. doi: 10.1016/0197-2456(88)90033-5. [DOI] [PubMed] [Google Scholar]
  24. Warner E., Lockwood G., Tritchler D., Boyd N. F. The risk of breast cancer associated with mammographic parenchymal patterns: a meta-analysis of the published literature to examine the effect of method of classification. Cancer Detect Prev. 1992;16(1):67–72. [PubMed] [Google Scholar]
  25. Whitehead J., Carlile T., Kopecky K. J., Thompson D. J., Gilbert F. I., Jr, Present A. J., Threatt B. A., Krook P., Hadaway E. Wolfe mammographic parenchymal patterns. A study of the masking hypothesis of Egan and Mosteller. Cancer. 1985 Sep 15;56(6):1280–1286. doi: 10.1002/1097-0142(19850915)56:6<1280::aid-cncr2820560610>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  26. Wolfe J. N. Breast patterns as an index of risk for developing breast cancer. AJR Am J Roentgenol. 1976 Jun;126(6):1130–1137. doi: 10.2214/ajr.126.6.1130. [DOI] [PubMed] [Google Scholar]
  27. Wolfe J. N. Risk for breast cancer development determined by mammographic parenchymal pattern. Cancer. 1976 May;37(5):2486–2492. doi: 10.1002/1097-0142(197605)37:5<2486::aid-cncr2820370542>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  28. Wolfe J. N., Saftlas A. F., Salane M. Mammographic parenchymal patterns and quantitative evaluation of mammographic densities: a case-control study. AJR Am J Roentgenol. 1987 Jun;148(6):1087–1092. doi: 10.2214/ajr.148.6.1087. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES